Failure of routine HIV-1 tests in a case involving transmission with preseroconversion blood components during the infectious window period
- PMID: 10889595
- DOI: 10.1001/jama.284.2.210
Failure of routine HIV-1 tests in a case involving transmission with preseroconversion blood components during the infectious window period
Abstract
Context: Current screening practices for blood donations have been successful in reducing human immunodeficiency virus (HIV) transmission through receipt of contaminated blood products. However, HIV-infected blood donations made prior to seroconversion and before high levels of viral replication occur could test negative using both serologic antigen and antibody tests. Testing based on nucleic acid amplification (NAT) is being implemented to screen for HIV-infected blood donated during this period, yet the issue of single vs minipool donation screening remains unresolved.
Objectives: To determine HIV-1 genetic linkage between virus in 2 HIV-1-infected recipients of blood components and virus in the donor, who was HIV antigen and antibody negative at the time of donation; to screen the blood donor's plasma with HIV NAT assays, including those currently proposed for use in US blood donation screening.
Design and setting: Case study conducted in October 1997 involving the Communicable Disease Centre, Singapore General Hospital, and the Singapore Blood Transfusion Service, Singapore.
Subjects: The blood donor and the 2 recipients of donor platelets and red blood cells.
Main outcome measures: Genetic analysis of the HIV-1 p17 coding region of gag and the C2V5 region of env to determine the genetic relatedness of virus from the donor and recipients; reactivity in quantitative and qualitative assays, and reactivity in donor screening HIV NAT assays in single donation and minipool screening contexts.
Results: Direct DNA sequencing demonstrated identical HIV-1 subtype E viral sequences in the donor and recipients. Based on comparisons of a qualitative and quantitative assay for HIV-1 RNA levels, a low level of viremia (range, 5-39 copies/mL in plasma) was estimated to be in the donor's undiluted blood at the time of donation. Additional testing using donor-screening NAT assays showed consistent detection of HIV RNA in the undiluted donor plasma whereas detection was inconsistent at the 1:16 and 1:24 dilution levels currently used in minipool screening of blood donations in the United States.
Conclusions: Transmission of HIV from a blood donor to a platelet recipient and a red blood cell recipient occurred in the preseroconversion infectious window period. The viral load in the implicated donation was estimated to be less than 40 copies/mL of plasma. Current US minipool HIV NAT screening protocols may not be sufficiently sensitive to detect all infectious window-period donations. JAMA. 2000;284:210-214
Comment in
-
Will blood transfusion ever be safe enough?JAMA. 2000 Jul 12;284(2):238-40. doi: 10.1001/jama.284.2.238. JAMA. 2000. PMID: 10889600 No abstract available.
Similar articles
-
First report of human immunodeficiency virus transmission via an RNA-screened blood donation.Vox Sang. 2004 Apr;86(3):171-7. doi: 10.1111/j.0042-9007.2004.00416.x. Vox Sang. 2004. PMID: 15078251
-
First transmission of human immunodeficiency virus Type 1 by a cellular blood product after mandatory nucleic acid screening in Germany.Transfusion. 2009 Sep;49(9):1836-44. doi: 10.1111/j.1537-2995.2009.02203.x. Epub 2009 May 11. Transfusion. 2009. PMID: 19453990
-
Window-period human immunodeficiency virus transmission to two recipients by an adolescent blood donor.Transfusion. 2004 Jun;44(6):929-33. doi: 10.1111/j.1537-2995.2004.03364.x. Transfusion. 2004. PMID: 15157262
-
[Detection of the nucleic acids of hepatitis B and C viruses and human immunodeficiency virus for the biological screening of blood donations. Viral Hepatitis and Retrovirus Working Groups and Subgroup for Molecular Biology Applied to Transfusion Virology of the French Blood Transfusion Society].Transfus Clin Biol. 1998 Apr;5(2):139-46. doi: 10.1016/s1246-7820(98)80004-9. Transfus Clin Biol. 1998. PMID: 9618839 Review. French.
-
Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?Transfus Clin Biol. 2004 Feb;11(1):26-32. doi: 10.1016/j.tracli.2003.12.003. Transfus Clin Biol. 2004. PMID: 14980546 Review.
Cited by
-
Frequency, causes, and new challenges of indeterminate results in Western blot confirmatory testing for antibodies to human immunodeficiency virus.Clin Vaccine Immunol. 2007 Jun;14(6):649-59. doi: 10.1128/CVI.00393-06. Epub 2007 Apr 4. Clin Vaccine Immunol. 2007. PMID: 17409223 Free PMC article. Review. No abstract available.
-
Early detection of human immunodeficiency virus type 1-specific B-lymphocyte-derived antibodies in a high-risk population.Clin Vaccine Immunol. 2009 Jul;16(7):1060-5. doi: 10.1128/CVI.00280-08. Epub 2009 May 27. Clin Vaccine Immunol. 2009. PMID: 19474262 Free PMC article.
-
Diagnostic algorithm for HBV safe transfusion.Blood Transfus. 2009 Jul;7(3):174-82. doi: 10.2450/2008.0062-08. Blood Transfus. 2009. PMID: 19657480 Free PMC article. Review. No abstract available.
-
Inactivation of a broad spectrum of viruses and parasites by photochemical treatment of plasma and platelets using amotosalen and ultraviolet A light.Transfusion. 2020 Jun;60(6):1319-1331. doi: 10.1111/trf.15807. Epub 2020 Apr 24. Transfusion. 2020. PMID: 32333396 Free PMC article. Review.
-
Translation of biomedical prevention strategies for HIV: prospects and pitfalls.J Acquir Immune Defic Syndr. 2013 Jun 1;63 Suppl 1(0 1):S12-25. doi: 10.1097/QAI.0b013e31829202a2. J Acquir Immune Defic Syndr. 2013. PMID: 23673881 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical